Skip to content
OpenCapital
Get started

iRadimed IRMD Increase (decrease) in contract liabilities and current deferred income

Increase (decrease) in contract liabilities and current deferred income at other companies

UFP Technologies logo
UFP TechnologiesUFPT
$387K+212%
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
——
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
——
Cohu logo
CohuCOHU
——

Other financials

Income statement

See full
Revenue$22.0M+12.6%
Gross profit$16.8M+13.3%
Operating income$7.2M+33.2%
Net income$5.8M+24.1%
EPS (diluted)$0.45+21.6%

Balance sheet

See full
Cash & equivalents$56.4M+12.0%
Total debt$59.2K-96.9%
Total equity$98.5M+9.4%
Total assets$114.4M+12.4%

Cash flow

See full
Operating cash flow$8.3M+93.2%
CapEx$403.0K-89.1%
Free cash flow$7.9M+1,226%

Valuation

See full
Market cap$1.21B+63.4%
P/E51.3×+13.8×
P/S14×+4.2×

Profitability

See full
Gross margin76.8%-0.1pp
Operating margin32.4%+2.3pp
Net margin27.4%+1.0pp
FCF margin28.4%+8.9pp

Returns & leverage

See full
Return on equity25%+1.2pp
Debt / equity0×0.0×
Current ratio7.1×-1.7×

Where this comes from

Reported directly by iRadimed in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerLiability.

The official record: iRadimed’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about iRadimed's increase (decrease) in contract liabilities and current deferred income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is iRadimed's increase (decrease) in contract liabilities and current deferred income?
iRadimed (IRMD) reported increase (decrease) in contract liabilities and current deferred income of $305K in Q1 2026.
How has iRadimed's increase (decrease) in contract liabilities and current deferred income changed year-over-year?
iRadimed's increase (decrease) in contract liabilities and current deferred income decreased by 44.2% year-over-year, from $547K to $305K.
What is the long-term trend for iRadimed's increase (decrease) in contract liabilities and current deferred income?
Over 2 years (2022 to 2025), iRadimed's increase (decrease) in contract liabilities and current deferred income has grown at a 73.4% compound annual growth rate (CAGR), from $530.58K to $1.6M.